Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus

Mycobacterium abscessus (Mab) is one of the most drug resistant bacteria with a high treatment failure rate. Antimicrobial peptides (AMPs) are alternative therapeutic agents against this infection. This study was aimed to assess the in vitro activities of thirteen AMPs (S5, S52, S6, S61, S62, S63, K...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudadech, Phantitra, Roytrakul, Sittiruk, Kaewprasert, Orawee, Sirichoat, Auttawit, Chetchotisakd, Ploenchan, Kanthawong, Sakawrat, Faksri, Kiatichai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592419/
https://www.ncbi.nlm.nih.gov/pubmed/34780520
http://dx.doi.org/10.1371/journal.pone.0260003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592419/
https://www.ncbi.nlm.nih.gov/pubmed/34780520
http://dx.doi.org/10.1371/journal.pone.0260003

Ejemplares similares